Pacer Advisors
CABA icon

Pacer Advisors’s Cabaletta Bio CABA Stock Holding History

Pacer Advisors’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8K Buy
+2,440
New +$8.03K ﹤0.01% 2367
2024
Q3 		– Sell
-589
Closed -$4.41K – 2583
2024
Q2 		$4.41K Sell
589
-1,064
-64% -$13K ﹤0.01% 3646
2024
Q1 		$28.2K Buy
+1,653
New +$35.5K ﹤0.01% 3374

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Pacer Advisors's CABA Position: Q2 2026 in Review

Pacer Advisors opened a new position in Cabaletta Bio (CABA) in Q2 2026: 2,440 shares worth $8K. The stake represents ﹤0.01% of the portfolio and ranks #2367 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in CABA as recently as Q2 2024.

Pacer Advisors first reported a position in CABA in Q1 2024 and has held it in 3 quarters since. The position peaked at $28.2K in Q1 2024. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Pacer Advisors held 2,440 shares of Cabaletta Bio worth $8K as of Q2 2026.
  • Cabaletta Bio was a new Pacer Advisors position in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2367 holding.
  • Pacer Advisors first reported a position in Cabaletta Bio in Q1 2024 and has held it in 3 quarters since.
  • Pacer Advisors's Cabaletta Bio position peaked at $28.2K in Q1 2024.
  • 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.